Goldman Sachs has highlighted a selection of stocks that are well-positioned for growth, emphasizing their defensive qualities and potential for upside. Among these, BrightSpring Health Services has received a buy rating with a price target of $71, attributed to its diverse service offerings in home health care, which are expected to drive growth in the aging care sector.
Samsara, a fleet management platform, is also noted for its solid execution and improving profit margins, with analysts recommending buying on any weakness. Ulta Beauty is seen as a strong contender for market share gains, with Goldman maintaining a $652 price target despite a 23% decline this year, citing robust performance and increased share repurchases.
Nvidia is praised for its capital allocation strategy, which is expected to enhance investor confidence and sustain growth, while Johnson & Johnson is recognized for its strong pharmaceutical franchise and significant balance sheet capacity. Overall, these insights from Goldman Sachs suggest a favorable outlook for these companies in the evolving market landscape